Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Pharmaceuticals to Launch DCGI-approved BRUKINSA® in India to Advance Treatment of Hematological Malignancies’.
The above information is a part of company’s filings submitted to BSE.